Designing Next-Generation Vaccines Against Common Pan-Allergens Using In Silico Approaches

Area of Science:

• Immunology
• Computational Biology
• Vaccine Design

Background:

• Next-generation allergy vaccines aim to induce allergen-blocking IgG responses by targeting IgE epitopes.
• Pan-allergens exhibit cross-reactivity due to conserved epitopes, necessitating broadly applicable vaccine strategies.
• Current vaccine design focuses on attenuated molecules to safely modulate immune responses.

Purpose of the Study:

• To computationally design novel allergy vaccine constructs against widespread pan-allergen families.
• To create safe, non-anaphylactic vaccine candidates by modifying allergenic peptides.
• To identify stable and immunogenic vaccine constructs with therapeutic potential.

Main Methods:

• Utilized a hapten-carrier concept, employing PreS or cholera enterotoxin B (CTB) fused with tetanus toxoid fragments (TTFrC) as carriers.
• Designed nonanaphylactic peptides (NAPs) from allergenic regions, modifying charged residues to reduce IgE and T cell reactivity.
• Screened vaccine constructs using physicochemical, secondary, and tertiary structure analyses via bioinformatic tools.

Main Results:

• Selected stable and high-quality vaccine constructs for each allergen family.
• Confirmed the suitability of constructs for recombinant expression at DNA, RNA, and protein levels.
• Predicted the presence of epitopes inducing tolerogenic interleukin-10.

Conclusions:

• Successfully designed putative next-generation allergy vaccines with immunotherapeutic potential.
• The developed vaccine constructs offer broad applicability for diverse allergic diseases.
• This computational approach provides a foundation for developing safe and effective allergy immunotherapy.